bg
S

SAB Biotherapeutics (SABS)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About SAB Biotherapeutics (SABS)

SAB Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company. It is focused on the development of immunotherapeutic polyclonal human antibodies to treat and prevent infectious diseases and immune and autoimmune disorders. Its DiversitAb pl... Read more

  • USD2.60
  • USD2.80
  • USD2.50
  • USD10.50
  • -0.40%
  • 3M
  • 134.00
  • 26.48k
  • 26M
  • 2.16
  • -53.70%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.